Related Experiment Video
Updated: Sep 9, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and chronic kidney disease: a
Maneeth Mylavarapu1, Israel Garcia2, Niharika Tanwar3
1Department of Public Health, Adelphi University, NY, USA.
Insights
Transcatheter aortic valve replacement (TAVR) shows better outcomes than Surgical aortic valve replacement (SAVR) for patients with aortic stenosis and chronic kidney disease, including lower mortality and fewer complications. However, TAVR increases risks for pacemaker implantation and vascular issues.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Interventional Cardiology
Background:
- Aortic stenosis (AS) management involves Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR).
- Limited data exist on postoperative outcomes for AS patients with co-existing Chronic Kidney Disease (CKD).
Purpose of the Study:
- To compare the postoperative clinical outcomes of TAVR versus SAVR in patients diagnosed with AS and CKD.
Main Methods:
- A systematic literature search was performed following PRISMA guidelines across PubMed, EMBASE, Scopus, and Google Scholar.
- Included studies compared TAVR and SAVR clinical outcomes specifically in patients with CKD.
- Meta-analysis of 23 studies involving 69,017 patients.
Main Results:
- TAVR was associated with significantly lower in-hospital mortality (OR 0.54), acute kidney injury (AKI) (OR 0.41), AKI requiring dialysis (OR 0.66), and overall postoperative complications (OR 0.34) compared to SAVR.
- TAVR also showed a significant reduction in AKI incidence (P < 0.00001) and postoperative complications (P < 0.0001).
- Conversely, TAVR had significantly higher odds of permanent pacemaker implantation (PPI) (OR 2.69) and major vascular complications (OR 2.56) than SAVR.
Conclusions:
- In patients with AS and CKD, TAVR demonstrates superior outcomes regarding in-hospital mortality, AKI incidence, and postoperative complications compared to SAVR.
- TAVR is linked to increased risks of PPI and major vascular complications, necessitating individualized risk assessment.
- TAVR represents a favorable alternative to SAVR for carefully selected CKD patients with AS.
Introduction:
Aortic stenosis (AS) is treated with either transcatheter aortic valve replacement (TAVR) or Surgical aortic valve replacement (SAVR). However, limited data exist to study the postoperative clinical outcomes in patients with AS and chronic kidney disease (CKD). The objective of this study is to compare TAVR and SAVR postoperative clinical outcomes in patients with AS and CKD.
Methods:
According to PRISMA guidelines, a comprehensive search was conducted across various databases such as PubMed, EMBASE, Scopus, and Google Scholar. Original studies that compared the clinical outcomes between TAVR and SAVR in patients with underlying CKD were included in the study.
Results:
Twenty-three studies with 69 017 patients with chronic kidney disease who underwent TAVR or SAVR were included in this study. Patients who underwent TAVR had significantly lower odds of in-hospital mortality (OR 0.54; 0.32, 0.91; P = 0.02), acute kidney injury [AKI] (OR 0.41; 0.33, 0.51; P < 0.00001), AKI requiring dialysis (OR 0.66; 0.48, 0.91; P = 0.01), and postoperative complications (OR 0.34; 0.23, 0.50; p<0.0001). However, patients who underwent TAVR had significantly higher odds of permanent pacemaker implantation [PPI] (OR 2.69; 1.96, 3.69; P < 0.0001), major vascular complications (OR 2.56; 1.09, 5.99; P = 0.03).
Conclusion:
In patients with AS and CKD, TAVR is associated with significantly lower in-hospital mortality, a reduced incidence of acute kidney injury, and fewer postoperative complications compared to SAVR. However, TAVR carries higher risks of pacemaker implantation and major vascular complications, highlighting the importance of individualized risk assessment and considering TAVR as a favorable alternative to SAVR in appropriately selected CKD patients.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Aortic Regurgitation III: Medical Management
Kidney Transplant I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations